Scribe Therapeutics Inc. · NASDAQ:SCTX
Marc L. Andreessen reported a 16.30% stake in Scribe Therapeutics Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 16, 2026
Marc L. Andreessen reported a 16.30% stake in Scribe Therapeutics Inc., 3,082,725 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).
- Stake
- 16.30%
- Shares
- 3,082,725
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AH Bio Fund II, L.P. | 12.60% | 2,385,075 |
| AH Equity Partners Bio II, L.L.C. | 12.60% | 2,385,075 |
| AH Bio Fund III, L.P. | 3.70% | 697,650 |
| AH Equity Partners Bio III, L.L.C. | 3.70% | 697,650 |
| Marc L. Andreessen | 16.30% | 3,082,725 |
| Benjamin A. Horowitz | 16.30% | 3,082,725 |
Source
Download original · View original at SEC